A Cheaper Market Is a Stricter MarketA Cheaper Market Is a Stricter Market

Germany has Europe’s largest market for medical cannabis, and in 2025 it grew fast. The country imported more than twice as much flower as the year before, from about 73 tonnes to just over 200.^{[1][1]1BfArMMedizinalcannabisverkehr – Ein-/AusfuhrOpen source ↗} The price fell as sharply as the volume rose. Bloomwell, a German cannabis company whose telemedicine platform fills prescriptions for self-paying patients, tracks what those patients pay for flower: across 2025 its average fell from EUR 8.33 a gram to EUR 5.23, while the number of different flower products on sale grew from 468 to 724.^{[2][2]2Bloomwell GroupThe Cannabis Barometer — Annual Review 2025Open source ↗}

Read quickly, that is good news: more supply at lower prices, a market that works. Read by anyone shipping cannabis into Germany, it is a warning. Every shipment has to pass inspection and testing before a pharmacy is allowed to sell it, and a shipment that fails is turned back. A turned-back shipment costs the same to sort out whether the gram was going to sell for eight euros or five: the same weeks lost, the same money tied up, the same production slot wasted. What shrank in 2025 is the profit left over to cover that cost. At EUR 8.33 a gram there was room to absorb a mistake.^{[2][2]2Bloomwell GroupThe Cannabis Barometer — Annual Review 2025Open source ↗} At EUR 5.23, with 724 products competing for the same shelf, there is much less.

The price fall is the clearest part of the record, and it is worth being exact about whose price it is. Bloomwell’s figure is the average paid by patients who buy through its own platform and pay out of their own pocket. It is not an official figure for every German pharmacy, and other trackers, counting differently, land higher. What none of them dispute is the direction. On Bloomwell’s own numbers, flower priced under EUR 6 a gram went from about 14% of the flower dispensed through its platform at the start of 2025 to close to 80% by the end.^{[2][2]2Bloomwell GroupThe Cannabis Barometer — Annual Review 2025Open source ↗}

The market got broader as it got cheaper. Bloomwell counted 468 different flower products at the start of the year and 724 by December.^{[2][2]2Bloomwell GroupThe Cannabis Barometer — Annual Review 2025Open source ↗} For a seller, more products means more competition. A shipment that turns up late, or with problems in its lab results or paperwork, is now one option among many, no longer scarce supply a buyer will wait for.

The pharmacy price is only the top of the stack. Below it sits the wholesale price: what a buyer in Germany pays a supplier, before the pharmacy adds its own margin. That price fell much less over 2025, because it was already low. GCX, a global exchange that tracks wholesale cannabis prices, put certified flower for the German market at EUR 1.75 to 2.45 a gram for low-THC strains in late 2025, and EUR 2.15 to 3.55 for high-THC. The figures were reported by the trade outlet StratCann.^{[4][4]4GCX via StratCannThe global cannabis trade in 2025: price compression, regulatory shifts, and market dynamicsOpen source ↗} Growing the flower costs less still: the same exchange put Colombian cultivation costs as low as about USD 0.06 a gram in spring 2025.^{[5][5]5GCX via StratCannRedrawing the Map: global cannabis trade in 2025Open source ↗}

But Germany does not pay for cheap flower. It pays for flower that has been tested, processed, and documented to the standard a pharmaceutical product needs (in the EU, a certification called EU-GMP), and that work does not get cheaper just because the flower does. As the pharmacy price falls toward the wholesale price, the gap between what a shipment sells for and what it costs to make it sellable narrows. That narrowing gap is where the cost of a mistake now comes out.

The cost of a turned-back shipment does not fall when the price does. The money that bought the flower stays frozen until the problem is resolved, and the production time the shipment consumed cannot be sold to anyone else. Both facts held at EUR 8.33 a gram, and they hold at EUR 5.23.^{[2][2]2Bloomwell GroupThe Cannabis Barometer — Annual Review 2025Open source ↗}

What changed is the money on the other side of that cost. When the market gets cheaper, each gram earns less to put toward fixing the problem, whether that means running the lab tests again or preparing the shipment a second time. The cost of getting it wrong stays flat while the revenue available to cover it drops.

When margins get tight, buyers get pickier. A German importer, the company that brings a shipment into the country, judges an offer on how much work it will create. The lab results have to satisfy its own quality team, and the paperwork has to be usable the day the goods arrive.

In a crowded market at a low price, the shipment that causes trouble is the one set aside, because an easier one is right behind it. Preparation is the difference between a shipment that moves and one that waits.

Germany’s 2025 boom produced a bigger market with less room for error. The more a buyer can choose from, the more a rejected shipment costs the seller who sent it. The lost sale is easy for the buyer to replace.

By March 2026, Bloomwell’s average had fallen again, to EUR 4.52 a gram, and the count of flower products it tracked had reached 887.^{[6][6]6Bloomwell GroupThe Cannabis Barometer — Q1 2026Open source ↗} A cheaper market is a stricter market, and the cheapest way through it is to get the shipment right the first time.